Neural Regeneration Research ›› 2026, Vol. 21 ›› Issue (1): 357-364.doi: 10.4103/NRR.NRR-D-24-00034

Previous Articles     Next Articles

Empowering the NSC-34 cell line as a motor neuron model: Cytosine arabinoside’s action

Giuseppe Vitale1, †, Susanna Amadio1 , Francesco Liguori1, 2, Cinzia Volonté1, 2, *   

  1. 1 Experimental Neuroscience and Neurological Disease Models, IRCCS Fondazione Santa Lucia, Rome, Italy;  2 Institute for System Analysis and Computer Science “Antonio Ruberti” (IASI), National Research Council (CNR), Rome, Italy  †Current address: Università Cattolica del Sacro Cuore and IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Largo A. Gemelli 8, 00168 Rome, Italy.
  • Online:2026-01-15 Published:2025-04-24
  • Contact: Cinzia Volonté, PhD, cinzia.volonte@cnr.it.
  • Supported by:
    The present work was supported by FATALSDrug Project [Progetti di Ricerca@CNR SAC.AD002.173.058] from National Research Council, Italy (to CV).

Abstract: The NSC-34 cell line is a widely recognized motor neuron model and various neuronal differentiation protocols have been exploited. Under previously reported experimental conditions, only part of the cells resemble differentiated neurons; however, they do not exhibit extensive and time-prolonged neuritogenesis, and maintain their duplication capacity in culture. The aim of the present work was to facilitate long-term and more homogeneous neuronal differentiation in motor neuron–like NSC-34 cells. We found that the antimitotic drug cytosine arabinoside promoted robust and persistent neuronal differentiation in the entire cell population. Long and interconnecting neuronal processes with abundant growth cones were homogeneously induced and were durable for up to at least 6 weeks in culture. Moreover, cytosine arabinoside was permissive, dispensable, and mostly irreversible in priming NSC-34 cells for neurite initiation and regeneration after mechanical dislodgement. Finally, the expression of the cell proliferation antigen Ki67 was inhibited by cytosine arabinoside, whereas the expression levels of neuronal growth associated protein 43, vimentin, and motor neuron–specific p75, Islet2, homeobox 9 markers were upregulated, as confirmed by western blot and/or confocal immunofluorescence analysis. Overall, these findings support the use of NSC-34 cells as a motor neuron model for properly investigating neurodegenerative mechanisms and prospectively identifying neuroprotective strategies.

Key words: cytosine arabinoside, Islet2, Hb9, Ki67, mitosis inhibition, neurite initiation, neurite regeneration, neuronal differentiation protocol, NSC-34, p75